Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Ankylosing Spondylitis (Bekhterev's Disease) to Musculoskeletal Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Ankylosing Spondylitis (Bekhterev's Disease) to Musculoskeletal Disorders Clinical Trials 20
Clinical Trials by Phase in E7 Countries 22
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Clinical Trials by End Point Status 27
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials 32
Prominent Drugs 33
Latest Clinical Trials News on Ankylosing Spondylitis (Bekhterev's Disease) 34
Apr 04, 2017: Galapagos announces three new Phase 2 Proof-of-Concept studiesbwith filgotinib 34
Mar 06, 2017: First CIMZIA Study of Its Kind Showed Minimal to No Transfer of Drug from Mother's Plasma to Breast Milk 34
Clinical Trial Profile Snapshots 35
Appendix 201
Abbreviations 201
Definitions 201
Research Methodology 202
Secondary Research 202
About GlobalData 203
Contact Us 203
Source 204

List of Tables
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, Global, Clinical Trials by Region, 2017* 6
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 14
Proportion of Ankylosing Spondylitis (Bekhterev's Disease) to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2017* 16
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
Proportion of Ankylosing Spondylitis (Bekhterev's Disease) to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2017* 21
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, Global, Clinical Trials by Phase, 2017* 24
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 25
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 26
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 27
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 28
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 29
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 31
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 32
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 33

List of Figures
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 13
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 14
Proportion of Ankylosing Spondylitis (Bekhterev's Disease) to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2017* 15
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Ankylosing Spondylitis (Bekhterev's Disease) to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2017* 20
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, Global, Clinical Trials by Phase (%), 2017* 24
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 25
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 26
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 27
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 28
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 29
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 30
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 32
Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 33
GlobalData Methodology 202

Companies Mentioned
Pfizer Inc
AbbVie Inc
Johnson & Johnson
Merck & Co Inc
Novartis AG
C. H. Boehringer Sohn AG & Co KG
UCB SA
Parexel International Corp
Amgen Inc
Aralez Pharmaceuticals Inc